Research & KnowledgeEvent: September 6, 2026
Zyndio published a recent trial combining GLP-1 therapy with resistance training showing participants retained 92% of their lean mass while losing significant body fat.
Published
Signal category
Research & Knowledge
Quote
“A recent trial combining GLP-1 therapy with resistance training showed participants retained 92% of their lean mass while losing significant body fat.”
— Brett Hudson|Zyndio team
Company
Zyndio
Peptides • Performance • Prescriptions • Doctor Visits
- Industry
- Public Health
- Company size
- 1 employees
Physician Guided Care, Built Around Your Goals. Every program begins with a board certified licensed medical doctor reviewing your case. No treatment is dispensed without physician approval, and prescriptions are fulfilled by U.S.-licensed pharmacies.
Founded 2026